A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)

Saved in:
Bibliographic Details
Title: A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
Authors: Sebban, C.1 catherine.sebban@lyon.unicancer.fr, Lefranc, A.2, Perrier, L.3,4, Moreau, P.5, Espinouse, D.6, Schmidt, A.7, Kammoun, L.8, Ghesquieres, H.1, Ferlay, C.2, Bay, J.O.9, Lissandre, S.10, Pérol, D.2, Michallet, M.11, Quittet, P.12
Source: European Journal of Cancer. Mar2012, Vol. 48 Issue 5, p713-720. 8p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2011.12.016